Both in Biotechnology
Neumora Therapeutics vs Armata Pharmaceuticals
Over the past year NMRA returned −80.3% and ARMP returned −33.7%; their daily moves had a correlation of 0.20.
NMRA −80.3% ARMP −33.7%Growth of $1, one year, split-adjusted
| Metric | NMRA | ARMP |
|---|---|---|
| Price | $0.5932 | $3.20 |
| Market cap | $111.5M | $119.0M |
| Today | +3.91% | +3.56% |
| 1 month | +25.9% | −16.9% |
| 6 months | −74.5% | −64.7% |
| Year to date | −66.9% | −49.0% |
| 1 year | −80.3% | −33.7% |
| Revenue growth (YoY) | — | +15.7% |
| Gross margin | — | 100.0% |
| Net margin | — | 2953.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 21.5× |
| Net cash | $63.9M | -$259.6M |
| Dividend yield | — | — |
| Volatility (60d) | 126.1% | 115.1% |
| Short % of float | 6.9% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).